Jennifer J. Kiser, PharmD

Jennifer J. Kiser, PharmD

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

Associate Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado


  • 2003 to 2006 – Antiretroviral Clinical Pharmacology Fellowship; University of Colorado Denver, Denver, Colorado
  • 2001 to 2002 – Pharmacy Practice Residency; University of California San Diego Medical Center, San Diego, California
  • 1997 to 2001 – Doctor of Pharmacy University of North Carolina Chapel Hill, Chapel Hill, North Carolina

Selected Publications

  1. AASLD/IDSA HCV Guidance Panel. Hepatitis C Guidance: AASLD-IDSA Recommendations for Testing, Managing, and Treating Adults Infected with Hepatitis C Virus. Hepatology EPub 2015 Jun 25.
  2. Rower JE, Meissner EG, Jimmerson LC, Osinusi A, Sims Z, Petersen T, Bushman LR, Wolfe P, McHutchison JG, Kottilil S, Kiser JJ*. Serum and cellular ribavirin pharmacokinetic and concentration effect analysis in HCV patients receiving sofosbuvir plus ribavirin. J Antimicrob Chemother. EPub 2015 May 1.
  3. Wu LS, Rower JE, Burton JR Jr, Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D’Argenio DZ, Kiser JJ*. Population pharmaockinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2015;59(4):2179-88.
  4. Jimmerson LC, Ray ML, Bushman LR, Anderson PL, Klein B, Rower JE, Zheng J-H, Kiser JJ*. Determination of Intracellular Ribavirin Mono-, Di-, and Triphosphate Concentrations by Solid Phase Extraction and HPLC-MS-MS Detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;978-979:163-72.
  5. Moorehead KJ, Burton JR, Jr., Everson GT, J-H Zheng, Kerr BJ, Bushman LR, Wang M, Ju C, Nydam T, Kiser JJ*. Intrahepatic Antiviral Quantification in a Patient Undergoing Orthotopic Cadaveric Liver Transplantation. J Antimicrob Chemother. 2015;70(1):315-7.
  6. Jimmerson LC, Zheng J-H, Bushman LR, MacBrayne CE, Anderson PL, Kiser JJ*. Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry. J Chrom B 2014;944:18-24.
  7. Hammond KP, Nielsen C, Linnebur SA, Langness JA, Ray G, Maroni P, Kiser JJ*. Priapism Induced by Boceprevir-CYP3A4 inhibition and Alpha-Adrenergic Blockade. Clinical Infectious Diseases 2014;58(1):e35-8.
  8. Hammond KP, Wolfe P, Burton JR, Predhomme JA, Ellis CM, Ray ML, Bushman LR, Kiser JJ*. Pharmacokinetic Interaction between Boceprevir and Etravirine in HIV/HCV Seronegative Volunteers. JAIDS 2013;62(1):67-73.
  9. Kiser JJ*, Burton JR, Everson GT.  Drug interactions in viral hepatitis.  Nature Reviews Gastroenterology & Hepatology 2013;10(10):596-606.
  10. Kiser JJ*, Flexner CW.  Direct Acting Antiviral Agents for Hepatitis C Virus Infection.  Annual Reviews in Pharmacology and Toxicology 2013;53:427-49.
  11. Kiser JJ*, Burton JR, Anderson PL, Everson GT.  Review and Management of Drug Interactions with Boceprevir and Telaprevir.  Hepatology 2012;55(5):1620-8.